ELVN earnings date and last-quarter result: next report 2026-08-12, last quarter beat, P/E -32.23. Updated 2026-07-23.
Enliven Therapeutics (ELVN) Research Hub
Enliven Therapeutics (ELVN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 41.49 USD (-0.07%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -32.23, market cap 3.83B. This hub links to the full technical, earnings and options research available for ELVN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 41.49 USD (-0.07%) |
| 52-week range | 36.955 USD – 62 USD |
| Trend regime | Range |
| 14-day RSI | 45.9 (Neutral) |
| Trailing P/E | -32.23 |
| Market cap | 3.83B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for ELVN
Covered Call on ELVN: how it works, illustrative setup around the real 41.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ELVN: how it works, illustrative setup around the real 41.49 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ELVN: how it works, illustrative setup around the real 41.49 USD price, max profit/loss, breakeven and when to use it. Educational.
ELVN technical analysis: range, last 41.49 USD, RSI 45.9, 52w range 36.955 USD–62 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ELVN in?
Enliven Therapeutics (ELVN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ELVN in an uptrend or downtrend?
As of 2026-10-26, ELVN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ELVN's trailing P/E ratio?
ELVN's trailing P/E is -32.23, with a market cap of 3.83B. See the earnings research page for full valuation detail.
When does ELVN next report earnings?
ELVN is next scheduled to report earnings on 2026-08-12.